Author(s):
Monika G. Shinde, Kaufiya D. Sayyad, Ganesh V. Swami, Priti B. Savant, Pooja R. Yalmar, Swati T. Mane
Email(s):
sayyadkaufi1997@gmail.com
DOI:
10.52711/2231-5713.2023.00036 
Address:
Monika G. Shinde, Kaufiya D. Sayyad*, Ganesh V. Swami, Priti B. Savant, Pooja R. Yalmar, Swati T. Mane
1,2,4,5,6Department of Pharmaceutical Chemistry SKVPM's Sahyadri College of Pharmacy, Methwade Dist. Solapur 413307, Maharashtra India.
3Mauli Shikshan Prasarak Mandals Mauli College of Pharmacy, Tondar - Udgir Road, Near Vilassugar Factory, Unit-II, Udgir, Maharashtra 413517 India.
*Corresponding Author
Published In:
Volume - 13,
Issue - 3,
Year - 2023
ABSTRACT:
Inflammation underlies a wide variety of physiological and pathological processes. The classic instigators of inflammation infection and tissue injury are at one end of a large range of adverse conditions that induce inflammation, and they trigger the recruitment of leukocytes and plasma proteins to the affected tissue site. Tissue stress or malfunction similarly induces an adaptive response, which is referred to here as Para-inflammation. This response relies mainly on tissue resident macrophages and is intermediate between the basal homeostatic state and a classic inflammatory response. Para-inflammation is probably responsible for the chronic inflammatory conditions that are associated with modern human diseases.
Cite this article:
Monika G. Shinde, Kaufiya D. Sayyad, Ganesh V. Swami, Priti B. Savant, Pooja R. Yalmar, Swati T. Mane. A Review on Inflammation and its Pharmacotherapy. Asian Journal of Pharmacy and Technology. 2023; 13(3):201-6. doi: 10.52711/2231-5713.2023.00036
Cite(Electronic):
Monika G. Shinde, Kaufiya D. Sayyad, Ganesh V. Swami, Priti B. Savant, Pooja R. Yalmar, Swati T. Mane. A Review on Inflammation and its Pharmacotherapy. Asian Journal of Pharmacy and Technology. 2023; 13(3):201-6. doi: 10.52711/2231-5713.2023.00036 Available on: https://ajptonline.com/AbstractView.aspx?PID=2023-13-3-9
REFERENCES:
1. Abbas A.B.; Lichtman A.H. Inflammation and Its Pharmacotherapy). "Ch.2 Innate Immunity". In Saunders (Elsevier). Basic Immunology. Functions and Disorders of the Immune System (3rd ed.).(2009)
2. Amanda Wages, Megan Troutman, Inflammation and Its Pharmacotherapy, Department of Pathology College of Veterinary Medicine The University of Georgia Athens, July 28, 2009 unit test3 pg. no 1-4, 6-7.
3. Ash ASF, Schild HO. Inflammation and Its Pharmacotherapy. Br J PharmacChemother 1966; 27:427-37.
4. Cotran; Kumar, Collins Inflammation and Its Pharmacotherapy Robbins Pathologic Basis of Disease. Philadelphia: W.B Saunders Company.(1998)
5. Dr.Junge C.M., Dr. Burande M.D. and Wadulkar R.D., Dr.poul B.N. Inflammation and Its Pharmacotherapy, Nirali publication page no.50-56
6. Ferrero-Miliani L, Nielsen OH, Andersen PS, Girardin SE; Nielsen; Andersen; Girardin Inflammation and Its Pharmacotherapy "Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation".(February 2007).Clin. Exp. Immunol. 147
7. Fields C, Drye L, m Vaidya V, Lyketsos C: Inflammation and Its Pharmacotherapy Celecoxib or naproxen treatment does not benefit depressive symptoms in persons age 70 and older: Findings from a randomized controlled trial. A M J Geriatr Psychiatry 2012; 20: 505-513.
8. Harsh Mohan. Inflammation and Its Pharmacotherapy. Sixth edition 2010, page no 130147.
9. Hashemian F, Majd M, Hosseini SM, Sharifi A, Panahi MVS, Bigdeli O: Inflammation and Its Pharmacotherapy A randomized, double-blind, placebo-controlled trial of celecoxib augmentation of sertraline in the treatment of a drug naive women with major depression. Klin Psikofarmakol Bul 2011; 21: S183-S184.
10. Jiang Z, Jiang JX, Zhang GX: Macrophages: Inflammation and Its Pharmacotherapy A double-edged sword in experimental autoimmune encephalomyelitis. Immunol Lett 2014; 160: 17-22.
11. K.D Tripathi, inflammation and its pharmacotherapy, Essentials of Medical Pharmacology, seventh edition, 2013, page no.192-209.
12. K.D. Rainsford. Inflammation and Its Pharmacotherapy, Biomedical Research Centre, Sheffield Hallam University, Howard Street, Sheffield, SI 1WB, UK © 2007 Springer. Pg no 2-5
13. Kumar, Rukmini; Clermont, Gilles; Vodovotz, Yoram; Chow, Carson C. Inflammation and Its Pharmacotherapy). "The dynamics of acute inflammation". Journal of Theoretical Biology. 230(2): 145–155(2004-09-21)
14. Martha white, Inflammation and its pharmacotherapy, J allergy CLIN Imunolvolumn 103 Nov3 part 2 1999 page no 1-4
15. Metcalfe DD, Kaliner M, Donlon MA. Inflammation its Pharmacotherapy. CRC Crit Rev immunol 1981;3:23-74
16. Ole Köhlera, Jesper Kroghc, Ole Morsa, and Michael Erikson Benrosc, Inflammation and Its Pharmacotherapy Bentham Science Publishers Current Neuropharmacology, 2016, Vol. 14,pg no2-5
17. Porth, Carol Inflammation and Its Pharmacotherapy Essentials of pahtophysiology: concepts of altered health states. Hagerstown, MD: Lippincott Williams and Wilkins. p. 270. (2007).
18. Uher R, Tansey KE, Dew T, Maier W, Mors O, Hauser J, Dernovsek MZ, Henigsberg N, Souery D, Farmer Inflammation and Its Pharmacotherapy A, McGuffin P: An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline. A M J Psychiatry 2014;
19. Uvnas B. Inflammation and its pharmacotherapy. Ann NY AcadSci 1964;116:880-890
20. Warner-Schmidt JL, Vanover KE, Chen EY, and Marshall JJ, Greengard P: Inflammation and Its Pharmacotherapy Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by anti-inflammatory drugs in mice and humans. Proc Natl AcadSci U S A 2011; 108: 9262- 9267.
21. Werner, Ruth. Inflammation and Its Pharmacotherapy A massage Therapist Guide to Pathology (4th ed.). Wolters Kluwer.(2009)